CCL2 and atherosclerosis: Moreover, A151 can significantly reduce the levels of two key inflammatory factors, monocyte chemotactic protein 1 (MCP-1) and vascular cell adhesion molecule 1 (VCAM-1), in the inflammatory process of atherosclerosis (Cheng et al., 2008).